Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2009
02/03/2009US7485724 2,4-pyrimidinediamine compounds and their uses
02/03/2009US7485664 Inhibitors of TACE
02/03/2009US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
02/03/2009US7485658 N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors
02/03/2009US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/03/2009US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
02/03/2009US7485643 Bicyclic inhibitors of MEK and methods of use thereof
02/03/2009US7485641 Substituted 3-amino-pyrrolidino-4-lactams
02/03/2009US7485638 Pyrimidine compounds
02/03/2009US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
02/03/2009CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
01/2009
01/29/2009WO2009015254A1 Triazine kinase inhibitors
01/29/2009WO2009014541A1 Alcohols containing imide moieties and reactive oligomers prepared therefrom
01/29/2009WO2009014100A1 p27 PROTEIN INDUCER
01/29/2009WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
01/29/2009WO2009013211A2 New pyrazol derivatives
01/29/2009WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses
01/29/2009WO2008150118A3 Novel amide derivative for inhibiting the growth of cancer cells
01/29/2009WO2008118379A3 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
01/29/2009US20090030057 Pharmaceutical composition of telmisartan
01/29/2009US20090030050 Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
01/29/2009US20090030032 Bicyclic Compound, Production and Use Thereof
01/29/2009US20090030018 Benzimidazole derivatives and their use for modulating the gabaalpha receptor complex
01/29/2009US20090030014 Indole Derivative Having Pgd2 Receptor Antagonist Activity
01/29/2009US20090030008 Piperazine derivatives and their use as therapeutic agents
01/29/2009US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009US20090029994 Trisubstituted amine compound
01/29/2009US20090029992 Substituted pyrazole compounds
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
01/29/2009US20090029976 e.g. [5-(1-cyclobutyl-piperidin-yloxy)-benzofuran-2-yl]-(4,4-difluoro-piperidin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor (H3 receptor); antidepressant, antiepileptic agent, analgesic, anticonvulsant, motion seackness
01/29/2009US20090029963 Pyrazol derivatives
01/29/2009US20090029905 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
01/29/2009US20090029405 Large stoke shift nir dyes
01/29/2009US20090028821 Prodrugs of cc-a1065 analogs
01/29/2009DE102007035333A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments
01/29/2009CA2694275A1 Organic compounds
01/29/2009CA2693187A1 New pyrazol derivatives
01/28/2009EP2019093A1 Urea type cinnamide derivative
01/28/2009EP2018377A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
01/28/2009EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/28/2009EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
01/28/2009EP1177181B1 Substituted bicyclic compounds
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
01/28/2009CN101356169A 吡嗪衍生物 Pyrazine derivatives
01/28/2009CN101356168A Quinazolines useful as modulators of voltage gated ion channels
01/28/2009CN101356161A Heterocyclic CETP inhibitors
01/28/2009CN101356160A Trisubstituted quinazolinone derivatives as vanilloid antagonists
01/28/2009CN101353345A Polyamine and polyamide conjugates and preparation thereof
01/28/2009CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
01/28/2009CN100455568C 6-position substituted indoline, production and use thereof as medicament
01/27/2009US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis
01/27/2009US7482470 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
01/27/2009US7482468 also informulation with an H1 receptor antagonist; inflammatory diseases, allergic conditions, obesity, metabolic syndrome and central nervous system disorders
01/27/2009US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay
01/27/2009US7482374 Pyrrolidine-2-ones as Factor Xa inhibitors
01/27/2009US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide
01/27/2009US7482368 Triamide-substituted heterobicyclic compounds
01/27/2009US7482358 2-(5-cyano-3-pyridyl)-4-(4-fluorophenyl)-4-(6-fluoro-3-pyridyl)-5-methyl-2-imidazoline; obesity, bulimia; antidiabetic agents; neuropeptide Y receptor antagonists
01/27/2009US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity
01/27/2009US7482352 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents
01/27/2009US7482350 4,5-disubstituted-2-aryl pyrimidines
01/27/2009US7482349 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5- dihydro-4H-imidazol-4-one
01/27/2009US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists
01/27/2009US7482343 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones
01/27/2009US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
01/27/2009US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
01/27/2009CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
01/27/2009CA2389280C Triazoles as farnesyl transferase inhibitors
01/27/2009CA2388646C Methods and compositions utilizing quinazolinones
01/27/2009CA2377226C Benzimidazole compounds and medicaments comprising the same
01/27/2009CA2290520C Inhibition of p38 kinase activity by aryl ureas
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009012109A2 Cyanine-containing compounds for cancer imaging and treatment
01/22/2009WO2009011880A2 Heterocyclic modulators of pkb
01/22/2009WO2009011850A2 Novel therapeutic compounds
01/22/2009WO2009011285A1 Heteroarylbenzene compounds
01/22/2009WO2009011131A1 Optical recording medium and azo copper chelate compound
01/22/2009WO2009010542A1 Cyclic amide compounds, method for the production thereof and the use thereof
01/22/2009WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists
01/22/2009WO2008142550A3 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
01/22/2009WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same
01/22/2009WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/22/2009US20090023932 Process for the Preparation of Telmisartan
01/22/2009US20090023931 Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
01/22/2009US20090023920 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
01/22/2009US20090023796 Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents
01/22/2009US20090023788 Treatment of CRTH2-mediated diseases and conditions
01/22/2009US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate
01/22/2009US20090023753 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents
01/22/2009US20090023752 N-Heterocyclylphthaldiamides as Insecticides
01/22/2009US20090023738 Diaminopyrimidines as modulators of the ep2 receptor
01/22/2009US20090023729 Trisubstituted amine compound
01/22/2009US20090023727 Phthalazinone derivatives
01/22/2009US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors
01/22/2009US20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase
01/22/2009US20090023708 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses